OTR Therapeutics
PrivateLast Round
Series A
Jun 1, 2025
Total Funding Raised
$100M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OTR Therapeutics is a biotechnology company that discovers and acquires preclinical assets to develop transformative therapies for oncology, immunology, and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OTR Therapeutics Comparables
Compare OTR Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindRank | 79% | |
| Nimbus Therapeutics | 73% | |
| Protuoso Biosciences | 72% | |
OTR Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 1, 2025 |
OTR Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sirona Capital | Series A |
| True Light Capital | Series A |
| Pfizer Ventures | Series A |
| Lilly Asia Ventures | Series A |
| Pfizer Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Dec 11, 2025
Multi-program deal with Zealand Pharma for metabolic disease therapeutics.
OTR Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OTR Therapeutics's valuation, stock price, and market status.